On June 26, Duality Biotherapeutics-B fell 5.18% in regular trading, trading at 160.0 HKD/share, with turnover of HKD 49.18 million.
Within the Biotechnology sector where Duality Biotherapeutics-B belongs, the sector is broadly under pressure. Among individual stocks, Akeso down 4.74%, Innovent Bio down 2.3%, BeiGene down 0.54%, 3SBio down 1.18%, Remegen down 1.93%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments